Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Red Hat Inc. (RHT) Is Down Sharply Following Q3 Report

RELATED NEWS
Trade RHT now with 

Red Hat Inc. (RHT: Quote) reported third quarter non-GAAP net income of $0.28 per share after the bell Monday, compared to $0.20 per share in the previous year. The consensus estimate was for EPS of $0.26.

Red Hat gapped open sharply lower Tuesday and is now down 3.22 at $42.83 on above average volume. The stock has dropped to a 2 1/2 month low and has fallen below its 200-day moving average.

Click here to receive FREE breaking news email alerts for Red Hat Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Beverages giant Coca-Cola Co. reported Tuesday a profit for the third quarter that decreased 14 percent from last year, despite higher worldwide volumes, reflecting a revenue drop. Adjusted earnings per share matched analysts' expectations, even as quarterly revenues missed their estimates. Following the announcement, the company's shares are trading more than five percent lower in early deals. Apple Inc. said Monday that its fourth quarter profit rose 13% from last year, driven by strong sales of its iPhones and Mac computers. The company's quarterly earnings per share also came in above analysts' expectations as did its quarterly sales. At the same time, the company gave an upbeat revenue forecast for the current quarter, which includes the all important holiday season. Programmable chipmaker Xilinx Inc. (XLNX) said Thursday after the markets closed that its second quarter profit rose 21% from last year, helped by higher revenue and better cost control. The company's quarterly earnings per share also came in above analysts' expectations as did its quarterly revenue....
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.